Economic news is pretty much nonexistent today, but the Dow Jones Industrial Average (DJINDICES:^DJI) is down by more than 0.7% despite some decent earnings reports from Verizon, Johnson & Johnson, and Travelers (NYSE:TRV).
Possibly causing a depressed mood on the index is a Wall Street Journal report that the Federal Reserve could increase the rate at which it is tapering off its bond-buying program by an additional $10 billion per month. According to an abbreviated version of the article on MarketWatch, the Fed could announce the further decrease in bond purchases at the close of its Jan. 28-29 meeting. This would bring bond purchases to $65 billion monthly, probably starting in February – compared to $85 billion per month as recently as December.
Travelers down despite good earnings report
Property and casualty insurer Travelers turned in a sweet fourth-quarter earnings report this morning, noting an increase in profit year over year to $988 million from $304 million. Full-year profits soared to $3.67 billion in 2013 from $2.47 billion for 2012, and share repurchases returned more than $3 billion in capital to shareholders last year.
At the heart of Travelers' impressive year was a relatively calm hurricane season, in addition to aggressive price increases. The stellar report hasn't helped the insurer's stock, which has lost 2.6% so far today.
In another corner of the insurance sector, UnitedHealth (NYSE:UNH) is holding its own amid the general bleakness, up 0.37% at noon EST. The giant health insurer was the subject of a couple of mixed analyst reports today.
The Street reiterated its buy rating on the stock this morning, noting the company's strong revenue growth, moderate debt levels, and strong earnings. The report also mentions the uptick in stock value, which has increased over the past year by nearly 34%. Monness Crespi Hardt apparently disagrees, giving UnitedHealth a sell rating earlier today. The report put a price target of $59 on the stock, which is trading at more than $72 per share. In any event, the positive report seems to be the more heavily weighted of the two, and the stock continues to climb.
Fool contributor Amanda Alix has no position in any stocks mentioned. The Motley Fool recommends Johnson & Johnson and UnitedHealth Group. The Motley Fool owns shares of Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
Does a Strong Start Make 2018 a Sure Winner for Stocks?
Find out whether the so-called "January effect" is real.
Meet the 2018 Dogs of the Dow
Learn the basics of this simple dividend-investing strategy.
The Dow's Worst Day in 2017
Even with big gains, there were some scary times for the average.